Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
62,886.72 -1,432.83 (-2.23%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
Relmada Therapeutics, Inc. (RLMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.7000 |
| Open | 3.6900 |
| Bid | 3.8100 x 400 |
| Ask | 3.8600 x 400 |
| Day's range | 3.6200 - 3.8700 |
| 52-week range | 2.3600 - 7.2230 |
| Volume | |
| Avg. volume | 213,326 |
| Market cap | 115.567M |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.2800 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.88 |
Insider MonkeyRelmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript March 19, 2024 Relmada Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.84, expectations were $-0.88. RLMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and […]
- Thomson Reuters StreetEvents
Q4 2023 Relmada Therapeutics Inc Earnings Call
Q4 2023 Relmada Therapeutics Inc Earnings Call
- GuruFocus.com
Relmada Therapeutics Inc Reports Full-Year and Q4 2023 Financial Results
Progress in CNS Treatments Amid Financial Challenges
© 2024 Yahoo. All rights reserved.